Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Michael CHEN
Michael CHEN
Positions:

Vice President, Head of Business Development

Company:

 Akeso Biopharma Inc.

Dr. Chen Chen (Michael) has joined Akeso as Vice President in July, 2020 and leads Akeso business development.

Before joining Akeso, Dr. Chen Chen (Michael) worked as Head of External Innovation APAC for Merck KGaA.  With alignment of Merck global R&D focus, Dr. Chen led collaborations with local pharmaceutical/biotech companies, investor groups and academic institutions in China and APAC areas. He encompassed scouting and evaluation of external opportunities including therapeutic assets (from discovery to clinical PoC stages), new drug targets/biomarkers, and novel discovery technologies.  He was also responsible for Merck global BD activities to leverage companies in China/APAC regions for Merck’s internalization and externalization opportunities at different R&D stages.  This particularly